Anxiety disorders and complex depression. Anxiety disorders and complex depression
Conditions
Interventions
Intervention 1: In the present study, participants were taking Anti-anxiety and antidepressant medication(Such as serotonin, Clonazepam, Buspirone, and venlafaxine) and also received eight sessions of
Sponsors
The university of kurdestan
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Anxiety Disorder and Comorbid Depression (According to Psychiatrist) Sanandaj resident No history of substance abuse The desire to participate and not receive any therapeutic intervention, including psychological and medication, at least in the last year
Exclusion criteria
Exclusion criteria: Has personality disorders A history of suicide illiterate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anxiety. Timepoint: pre test, post test and follow up(one month after treatment). Method of measurement: Beck Anxiety Inventory.;Depression. Timepoint: pre test, post test and follow up(one month after treatment). Method of measurement: Beck Depression Inventory. | — |
Secondary
| Measure | Time frame |
|---|---|
| Emotional regulaition. Timepoint: Before and after 8 sessions of treatment. Method of measurement: Use the emotion regulation difficulty questionnaire.;Negative repetitive thoughts. Timepoint: Before and after 8 sessions of treatment. Method of measurement: Using Negative repetitive Thought Questionnaire.;Intolerance of Uncertainly. Timepoint: Before and after 8 sessions of treatment. Method of measurement: Use of uncertainty intolerance questionnaire.;Anxiety Sensitivity. Timepoint: Before and after 8 sessions of treatment. Method of measurement: Anxiety Sensitivity Questionnaire.;Experiential Avoidance. Timepoint: Before and after 8 sessions of treatment. Method of measurement: Experiential Avoidance Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactmehdi zemestany
the university of kurdestan
Outcome results
None listed